Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.823. It has been cited 241 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.823
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH HHS
Grant: 5P01 AI118688-04
NIAMS NIH HHS
Grant: R01 AR071522
NCATS NIH HHS
Grant: UL1 TR001863
NHLBI NIH HHS
Grant: K24 HL137013
NIAID NIH HHS
Grant: P01 AI118688
NCI NIH HHS
Grant: R01 CA094143
NHLBI NIH HHS
Grant: R35 HL140026
NCATS NIH HHS
Grant: UL1 TR001866
NHGRI NIH HHS
Grant: UM1 HG006504
NIAID NIH HHS
Grant: R01 AI136972
NHGRI NIH HHS
Grant: U24 HG008956
NHLBI NIH HHS
Grant: K23 HL138461
NIAID NIH HHS
Grant: U19 AI077439
NIH HHS
Grant: 1F30 DK123915-01
The Role of RFX6 in Type 1 Diabetes
NIDDK NIH HHS
Grant: F30 DK123915
NIAMS NIH HHS
Grant: P30 AR070155
NIAID NIH HHS
Grant: R01 AI163029
NIGMS NIH HHS
Grant: R35 GM134922
NIGMS NIH HHS
Grant: T32 GM067547
NHGRI NIH HHS
Grant: U01 HG012192
NIH HHS
Grant: HL151552
NIAID NIH HHS
Grant: K24 AI144048
NHLBI NIH HHS
Grant: R01 HL151552
NIH HHS
Grant: U19 AI1077439
CSRD VA
Grant: IK2 CX001034
NIAID NIH HHS
Grant: R01 AI088364
NIBIB NIH HHS
Grant: T32 EB009383
National Institutes of Health
Grant: 5U24HG008956-02
NHGRI Genome Sequencing Program Coordinating Center
National Institutes of Health
Grant: 5IK2CX001034-05
Immune Mechanisms of Large-airway Lymphocytic Bronchitis
National Institutes of Health
Grant: 8U01HG012192-05
Fine mapping rheumatic disease variants using functional genomic sequencing
National Institutes of Health
Grant: 1R01HL151552-01
Telomere Dysfunction as a cause of Chronic Lung Allograft Dysfunction
National Institutes of Health
Grant: 5UM1HG006504-07
Yale Center for Mendelian Genomics
National Institutes of Health
Grant: 5R01AI088364-15
Inborn errors of immunity in children with herpes simplex encephalitis
National Institutes of Health
Grant: 5R35HL140026-03
Precision Medicine in the Acute Respiratory Distress Syndrome
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 1K23HL138461-01A1
Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic Sequencing
National Institutes of Health
Grant: 3R35GM134922-05S1
Robust and efficient statistical inference methods for genomics
National Institutes of Health
Grant: 5R01AI136972-03
Genetic regulation and immunological function of ERAP2 haplotypes
National Institutes of Health
Grant: 1F32GM013039-01
MOLECULAR ANALYSIS OF THE YEAST HEAT SHOCK TRANSCRIPTION
National Institutes of Health
Grant: 5P01AI118688-02
Disruption of T cell tolerance in type 1 diabetes
National Institutes of Health
Grant: 5R01AR071522-04
Fine mapping rheumatic disease variants using functional genomic sequencing
Howard Hughes Medical Institute
FWCI
12.54
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
Additional file 2 of SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
Additional file 1 of Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Additional file 1 of Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Additional file 1 of Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
Additional file 1 of Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure